Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Antonella Messina
Imatinib and Everolimus in Patients With Progressing Advanced Chordoma: A Phase 2 Clinical Study
Cancer
Cancer Research
Oncology
Response to Imatinib in Villonodular Pigmented Synovitis (PVNS) Resistant to Nilotinib
Clinical Sarcoma Research
Oncology
Related publications
A Phase 2 and Biomarker Study of Cabozantinib in Patients With Advanced Cholangiocarcinoma
Cancer
Cancer Research
Oncology
Phase I/Ii Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers
Oncologist
Cancer Research
Medicine
Oncology
Phase 2 Study of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma
Journal of Gastroenterology
Gastroenterology
Correction: Phase 2 Study of Pembrolizumab in Patients With Advanced Rare Cancers
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Phase I Clinical Trial Combining Imatinib Mesylate and IL-2
OncoImmunology
Oncology
Allergy
Immunology
Imatinib Mesylate for Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1: A Phase 2 Trial
The Lancet Oncology
Oncology
Correction 2: Everolimus (EVE) and Exemestane (EXE) in Patients With Advanced Breast Cancer Aged ≥ 65 Years: New Lessons for Clinical Practice From the EVA Study
Oncotarget
Oncology
A Phase I Study of Indoximod in Patients With Advanced Malignancies
Oncotarget
Oncology
Neue Daten Zu Imatinib Und Everolimus
Uro-News
